Targeting DTX2/UFD1-mediated FTO degradation to regulate antitumor immunity. - Cui YH; Wei J; Fan H; Li W; Zhao L; Wilkinson E; Peterson J; Xie L; Zou Z; Yang S; Applebaum MA; Kline J; et al. (Proceedings of the National Academy of Sciences of the United States of America, 2024)